HDAC6 and Alzheimer disease: However, HDAC6 inhibitors to increase microtubule acetylation have been shown to rescue phenotypes across models of multiple neurodegenerative diseases with impaired axonal transport, such as AD, PD, HD, ALS, and CMT (31, 132, 154, 156, 180–188).